146 related articles for article (PubMed ID: 38611660)
1. Prognostic Molecular Biomarkers in Breast Cancer Lesions with Non-Mass Enhancement on MR.
Wang ML; Chang YP; Wu CH; Chen CH; Gueng MK; Wu YY; Chai JW
Diagnostics (Basel); 2024 Mar; 14(7):. PubMed ID: 38611660
[TBL] [Abstract][Full Text] [Related]
2. Significance of Additional Non-Mass Enhancement in Patients with Breast Cancer on Preoperative 3T Dynamic Contrast Enhanced MRI of the Breast.
Cho YH; Cho KR; Park EK; Seo BK; Woo OH; Cho SB; Bae JW
Iran J Radiol; 2016 Jan; 13(1):e30909. PubMed ID: 27127579
[TBL] [Abstract][Full Text] [Related]
3. Interobserver variability and likelihood of malignancy for fifth edition BI-RADS MRI descriptors in non-mass breast lesions.
Lunkiewicz M; Forte S; Freiwald B; Singer G; Leo C; Kubik-Huch RA
Eur Radiol; 2020 Jan; 30(1):77-86. PubMed ID: 31392476
[TBL] [Abstract][Full Text] [Related]
4. The MRI characteristics of non-mass enhancement lesions of the breast: associations with malignancy.
Aydin H
Br J Radiol; 2019 Apr; 92(1096):20180464. PubMed ID: 30673299
[TBL] [Abstract][Full Text] [Related]
5. Dynamic contrast-enhanced breast magnetic resonance imaging findings that affect the magnetic resonance-directed ultrasound correlation of non-mass enhancement lesions: a single-center retrospective study.
Coskun Bilge A; Demir PI; Aydin H; Bostanci IE
Br J Radiol; 2022 Apr; 95(1132):20210832. PubMed ID: 34990263
[TBL] [Abstract][Full Text] [Related]
6. Clumped vs non-clumped internal enhancement patterns in linear non-mass enhancement on breast MRI.
Chen ST; Covelli J; Okamoto S; Daniel BL; DeMartini WB; Ikeda DM
Br J Radiol; 2021 Feb; 94(1118):20201166. PubMed ID: 33332980
[TBL] [Abstract][Full Text] [Related]
7. Association of Different MRI BIRADS Descriptors With Malignancy in Non Mass-Like Breast Lesions.
Gity M; Ghazi Moghadam K; Jalali AH; Shakiba M
Iran Red Crescent Med J; 2014 Dec; 16(12):e26040. PubMed ID: 25763248
[TBL] [Abstract][Full Text] [Related]
8. Management of Non-Mass Enhancement at Breast Magnetic Resonance in Screening Settings Referred for Magnetic Resonance-Guided Biopsy.
de Faria Castro Fleury E; Castro C; do Amaral MSC; Roveda Junior D
Breast Cancer (Auckl); 2022; 16():11782234221095897. PubMed ID: 35602239
[TBL] [Abstract][Full Text] [Related]
9. Diagnostic value of mammography for accompanying non-mass enhancement on preoperative breast MRI.
Kim Y; Jung HK; Park AY; Ko KH; Jang H
Acta Radiol; 2022 Aug; 63(8):1032-1042. PubMed ID: 34260322
[TBL] [Abstract][Full Text] [Related]
10. Magnetic resonance imaging of breast cancer and correlation with prognostic factors.
Chang YW; Kwon KH; Choi DL; Lee DW; Lee MH; Lee HK; Yang SB; Kim Y; Seo DY
Acta Radiol; 2009 Nov; 50(9):990-8. PubMed ID: 19863408
[TBL] [Abstract][Full Text] [Related]
11. Comparison of Dynamic Contrast-Enhanced MRI and Non-Mono-Exponential Model-Based Diffusion-Weighted Imaging for the Prediction of Prognostic Biomarkers and Molecular Subtypes of Breast Cancer Based on Radiomics.
Zhang L; Zhou XX; Liu L; Liu AY; Zhao WJ; Zhang HX; Zhu YM; Kuai ZX
J Magn Reson Imaging; 2023 Nov; 58(5):1590-1602. PubMed ID: 36661350
[TBL] [Abstract][Full Text] [Related]
12. Magnetic resonance imaging features for differentiating breast papilloma with high-risk or malignant lesions from benign papilloma: a retrospective study on 158 patients.
Wang LJ; Wu P; Li XX; Luo R; Wang DB; Guan WB
World J Surg Oncol; 2018 Dec; 16(1):234. PubMed ID: 30558621
[TBL] [Abstract][Full Text] [Related]
13. Is there different correlation with prognostic factors between "non-mass" and "mass" type invasive ductal breast cancers?
Jiang L; Zhou Y; Wang Z; Lu X; Chen M; Zhou C
Eur J Radiol; 2013 Sep; 82(9):1404-9. PubMed ID: 23540946
[TBL] [Abstract][Full Text] [Related]
14. Non-mass enhancement breast lesions: MRI findings and associations with malignancy.
Liu G; Li Y; Chen SL; Chen Q
Ann Transl Med; 2022 Mar; 10(6):357. PubMed ID: 35433999
[TBL] [Abstract][Full Text] [Related]
15. Relationships Between MRI Breast Imaging-Reporting and Data System (BI-RADS) Lexicon Descriptors and Breast Cancer Molecular Subtypes: Internal Enhancement is Associated with Luminal B Subtype.
Grimm LJ; Zhang J; Baker JA; Soo MS; Johnson KS; Mazurowski MA
Breast J; 2017 Sep; 23(5):579-582. PubMed ID: 28295860
[TBL] [Abstract][Full Text] [Related]
16. Discriminative Factors of Malignancy of Ipsilateral Nonmass Enhancement in Women With Newly Diagnosed Breast Cancer on Initial Staging Breast MRI.
Jirarayapong J; Chikarmane SA; Portnow LH; Farah S; Gombos EC
J Magn Reson Imaging; 2024 May; 59(5):1725-1739. PubMed ID: 37534882
[TBL] [Abstract][Full Text] [Related]
17. Breast Nonmass Enhancement Detected with MRI: Uility and Lesion Characterization with Second-Look Ultrasonography.
Hsu HH; Chang TH; Chou YC; Peng YJ; Ko KH; Chang WC; Lin YP; Hsu GC; Yu JC
Breast J; 2015; 21(6):579-87. PubMed ID: 26390913
[TBL] [Abstract][Full Text] [Related]
18. Identification of Preoperative Magnetic Resonance Imaging Features Associated with Positive Resection Margins in Breast Cancer: A Retrospective Study.
Kang JH; Youk JH; Kim JA; Gweon HM; Eun NL; Ko KH; Son EJ
Korean J Radiol; 2018; 19(5):897-904. PubMed ID: 30174479
[TBL] [Abstract][Full Text] [Related]
19. An artificial intelligence system using maximum intensity projection MR images facilitates classification of non-mass enhancement breast lesions.
Wang L; Chang L; Luo R; Cui X; Liu H; Wu H; Chen Y; Zhang Y; Wu C; Li F; Liu H; Guan W; Wang D
Eur Radiol; 2022 Jul; 32(7):4857-4867. PubMed ID: 35258676
[TBL] [Abstract][Full Text] [Related]
20. Magnetic resonance imaging diagnosis of non-mass enhancement of the breast.
Kubota K; Mori M; Fujioka T; Watanabe K; Ito Y
J Med Ultrason (2001); 2023 Jul; 50(3):361-366. PubMed ID: 36801992
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
